These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 7503821)

  • 41. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R
    BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
    Wizla-Derambure N; Michaud L; Sardet A; Deschildre A; Loeuille GA; Tassin E; Loire N; Buisine C; Boutry E; Dias J; Hecquet F; Turck D
    Arch Pediatr; 1998 Apr; 5(4):378-83. PubMed ID: 9759156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
    [No Abstract]   [Full Text] [Related]  

  • 44. Where we are now with rhDNase.
    Geddes DM; Shah PL
    Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
    Nasr SZ; Kuhns LR; Brown RW; Hurwitz ME; Sanders GM; Strouse PJ
    Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Eisenberg JD; Aitken ML; Dorkin HL; Harwood IR; Ramsey BW; Schidlow DV; Wilmott RW; Wohl ME; Fuchs HJ; Christiansen DH; Smith AL
    J Pediatr; 1997 Jul; 131(1 Pt 1):118-24. PubMed ID: 9255202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC; McElvaney NG; Birrer P; Shak S; Robinson WW; Jolley C; Wu M; Chernick MS; Crystal RG
    N Engl J Med; 1992 Mar; 326(12):812-5. PubMed ID: 1538726
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
    Oster G; Huse DM; Lacey MJ; Regan MM; Fuchs HJ
    Ann Pharmacother; 1995 May; 29(5):459-64. PubMed ID: 7655127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP; Wallis CE
    Cochrane Database Syst Rev; 2003; (3):CD001127. PubMed ID: 12917899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of administration of aerosolized recombinant human deoxyribonuclease on resting energy expenditure in patients with cystic fibrosis.
    Amin N; Dozor AJ
    Pediatr Pulmonol; 1994 Sep; 18(3):150-4. PubMed ID: 7800431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
    Paul K; Rietschel E; Ballmann M; Griese M; Worlitzsch D; Shute J; Chen C; Schink T; Döring G; van Koningsbruggen S; Wahn U; Ratjen F;
    Am J Respir Crit Care Med; 2004 Mar; 169(6):719-25. PubMed ID: 14684561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
    Davies J; Trindade MT; Wallis C; Rosenthal M; Crawford O; Bush A
    Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A
    JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
    Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM
    J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
    Christopher F; Chase D; Stein K; Milne R
    J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
    Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation.
    Bakker EM; Volpi S; Salonini E; van der Wiel-Kooij EC; Sintnicolaas CJ; Hop WC; Assael BM; Merkus PJ; Tiddens HA
    Eur Respir J; 2011 Dec; 38(6):1328-35. PubMed ID: 21737560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.
    Geller DE; Eigen H; Fiel SB; Clark A; Lamarre AP; Johnson CA; Konstan MW
    Pediatr Pulmonol; 1998 Feb; 25(2):83-7. PubMed ID: 9516090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD; Nahata MC
    J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.